Newsroom
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, was interviewed about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Read the story.
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, was interviewed about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Read the story.
January 12, 2021
Dr. Barbara Taylor, Infectious Diseases, contributed to this second KENS 5 TV news segment on the Novavax trial launch, emphasizing that minorities are desperately needed for clinical trials because the inclusion of diverse groups in trials is the only way to make effective vaccines for all. Read and watch the story.
January 11, 2021
Dr. Jason Bowling, Infectious Diseases, spoke to KENS 5 TV viewers about the recent study that suggests the Pfizer vaccine is effective against coronavirus variants. Read and watch the story.
January 11, 2021
Dr. Gabriel de Erausquin, Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was interviewed by Jon Hamilton, NPR correspondent, regarding an article recently published in Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association; the article cites decades of scientific evidence suggesting it is very likely that COVID-19 will have long-term effects on the brains […]
January 8, 2021
Dr. Barbara Taylor, Infectious Diseases, was quoted in this story about the launch of the Novavax vaccine clinical trial at UT Health San Antonio and clinical partner University Health. 500 San Antonians are needed for this two-year COVID-19 vaccine study. Read the story.